Real platforms. Real data. Real clinical impact.
Chronus Health
Co-founded and built a CLIA-waiver candidate POC device for CBC, CMP, and electrolytes from undiluted whole blood — no sample prep, no optical detection. From bench feasibility through IRB-approved clinical studies and FDA pre-submission.
Confidential — IVD Startup
End-to-end development of a multiplexed electrochemical biosensor for a serum protein panel. Scope included aptamer selection and screening, surface chemistry optimization, and prototype validation against reference methods.
Confidential — IVD Startup
Feasibility study for electrochemical detection of a small-molecule hormone using a competitive assay format. Scope included assay design, surface chemistry optimization, and proof-of-concept validation against reference methods.
Confidential — Diagnostics Company
Development of ion-selective electrodes (ISEs) for simultaneous electrochemical detection of sodium, potassium, and calcium in whole blood. Scope included membrane formulation, electrode fabrication, and clinical correlation against a reference analyzer.
Confidential — MedTech Company
Development of an amperometric glucose biosensor for whole-blood detection. Scope included enzyme immobilization chemistry, mediator selection, electrode optimization, and performance validation across clinically relevant glucose ranges.
Let's talk through your project. Initial calls are 30 minutes and completely free.